CAD 1.29
(9.83%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 2.53 Billion USD | -6.96% |
2022 | 2.72 Billion USD | 50.01% |
2021 | 1.81 Billion USD | 44.84% |
2020 | 1.25 Billion USD | 190.39% |
2019 | 432.44 Million CAD | 135.94% |
2018 | 183.28 Million CAD | 212.32% |
2017 | 58.68 Million CAD | 379366.01% |
2016 | 15.46 Thousand CAD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 2.63 Billion USD | 1.62% |
2024 Q2 | 1.97 Billion USD | 1.49% |
2023 FY | 2.53 Billion USD | -6.96% |
2023 Q4 | 2.53 Billion USD | -6.79% |
2023 Q3 | 2.72 Billion USD | 2.95% |
2023 Q2 | 2.64 Billion USD | -2.76% |
2023 Q1 | 2.72 Billion USD | 0.54% |
2022 Q2 | 2.24 Billion CAD | 2.69% |
2022 Q1 | 2.18 Billion CAD | 18.77% |
2022 Q3 | 2.52 Billion CAD | 12.79% |
2022 Q4 | 2.7 Billion USD | 7.1% |
2021 Q4 | 1.83 Billion CAD | 2.6% |
2021 Q3 | 1.79 Billion CAD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Aurora Cannabis Inc. | 236.8 Million CAD | -972.064% |
Avicanna Inc. | 13.99 Million CAD | -18034.724% |
Avant Brands Inc. | 33.22 Million CAD | -7541.101% |
Cardiol Therapeutics Inc. | 8.45 Million CAD | -29929.326% |
Crescita Therapeutics Inc. | 5.77 Million CAD | -43852.207% |
Knight Therapeutics Inc. | 198.62 Million CAD | -1178.146% |
MediPharm Labs Corp. | 10.93 Million CAD | -23122.461% |
OrganiGram Holdings Inc. | 26.83 Million CAD | -9361.387% |
Canopy Growth Corporation | 799.82 Million CAD | -217.405% |
Willow Biosciences Inc. | 3.23 Million CAD | -78326.923% |
Auxly Cannabis Group Inc. | 210.85 Million CAD | -1103.982% |